Neuroendocrine Control of the Menstrual Cycle

Yen & Jaffe's Reproductive Endocrinology

Volumn , Issue , 2009, Pages 139-154

  Hall, Janet E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70949102159     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4907-4.00007-3     Document Type: Chapter

References (137)

1. Conn P.M., Crowley W.F. Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994, 45:391-405.
2. Crowley W.F., Pitteloud N., Seminara S. New genes controlling human reproduction and how you find them. Trans Am Clin Climatol Assoc 2008, 119:29-38.
3. Falardeau J., Chung W.C., Beenken A., et al. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest 2008, 118(8):2822-2831.
4. Rance N.E., Young W.S., McMullen N.T. Topography of neurons expressing luteinizing hormone-releasing hormone gene transcripts in the human hypothalamus and basal forebrain. J Comp Neurol 1994, 339(4):573-586.
5. Neill J.D. GnRH and GnRH receptor genes in the human genome. Endocrinology 2002, 143(3):737-743.
6. McCann S.M., Karanth S., Mastronardi C.A., et al. Control of gonadotropin secretion by follicle-stimulating hormone-releasing factor, luteinizing hormone-releasing hormone, and leptin. Arch Med Res 2001, 32(6):476-485.
7. Belchetz P.E., Plant T.M., Nakai Y., et al. Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science 1978, 202(4368):631-633.
8. Wetsel W.C., Valenca M.M., Merchenthaler I., et al. Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. Proc Natl Acad Sci U S A 1992, 89(9):4149-4153.
9. Herbison A.E. Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. Endocr Rev 1998, 19(3):302-330.
10. Perkins R.B., Hall J.E., Martin K.A. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation. J Clin Endocrinol Metab 1999, 84(6):1905-1911.
11. Berga S.L., Loucks A.B., Rossmanith W.G., et al. Acceleration of luteinizing hormone pulse frequency in functional hypothalamic amenorrhea by dopaminergic blockade. J Clin Endocrinol Metab 1991, 72(1):151-156.
12. Shoupe D., Montz F.J., Lobo R.A. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women. J Clin Endocrinol Metab 1985, 60(1):178-183.
13. Quigley M.E., Yen S.S. The role of endogenous opiates in LH secretion during the menstrual cycle. J Clin Endocrinol Metab 1980, 51(1):179-181.
14. Seminara S.B. Kisspeptin in reproduction. Semin Reprod Med 2007, 25(5):337-343.
15. Roa J., Aguilar E., Dieguez C., et al. New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function. Front Neuroendocrinol 2008, 29(1):48-69.
16. Kauffman A.S., Clifton D.K., Steiner R.A. Emerging ideas about kisspeptin-GPR54 signaling in the neuroendocrine regulation of reproduction. Trends Neurosci 2007, 30(10):504-511.
17. Kerdelhue B., Brown S., Lenoir V., et al. Timing of initiation of the preovulatory luteinizing hormone surge and its relationship with the circadian cortisol rhythm in the human. Neuroendocrinology 2002, 75(3):158-163.
18. Lavoie H.B., Marsh E.E., Hall J.E. Absence of apparent circadian rhythms of gonadotropins and free alpha-subunit in postmenopausal women: evidence for distinct regulation relative to other hormonal rhythms. J Biol Rhythms 2006, 21(1):58-67.
19. Boyar R., Finkelstein J., Roffwarg H., et al. Synchronization of augmented luteinizing hormone secretion with sleep during puberty. N Engl J Med 1972, 287(12):582-586.
20. Filicori M., Flamigni C., Vizziello G., et al. Hypothalamic control of gonadotropin secretion in the human menstrual cycle. Prog Clin Biol Res 1986, 225:55-74.
21. Soules M.R., Steiner R.A., Cohen N.L., et al. Nocturnal slowing of pulsatile luteinizing hormone secretion in women during the follicular phase of the menstrual cycle. J Clin Endocrinol Metab 1985, 61(1):43-49.
22. Hall J.E., Sullivan J.P., Richardson G.S. Brief wake episodes modulate sleep-inhibited luteinizing hormone secretion in the early follicular phase. J Clin Endocrinol Metab 2005, 90(4):2050-2055.
23. Childs G.V., Unabia G., Rougeau D. Cells that express luteinizing hormone (LH) and follicle-stimulating hormone (FSH) beta-subunit messenger ribonucleic acids during the estrous cycle: the major contributors contain LH beta, FSH beta, and/or growth hormone. Endocrinology 1994, 134(2):990-997.
24. Stanton P.G., Burgon P.G., Hearn M.T., Robertson D.M. Structural and functional characterisation of hFSH and hLH isoforms. Mol Cell Endocrinol 1996, 125(1-2):133-141.
25. Wide L. Median charge and charge heterogeneity of human pituitary FSH, LH and TSH.I. Zone electrophoresis in agarose suspension. Acta Endocrinol (Copenh) 1985, 109(2):181-189.
26. Smith P.L., Baenziger J.U. Molecular basis of recognition by the glycoprotein hormone-specific N-acetylgalactosamine-transferase. Proc Natl Acad Sci U S A 1992, 89(1):329-333.
27. Wide L., Naessen T., Sundstrom-Poromaa I., Eriksson K. Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men. J Clin Endocrinol Metab 2007, 92(11):4410-4417.
28. Sharpless J.L., Supko J.G., Martin K.A., Hall J.E. Disappearance of endogenous luteinizing hormone is prolonged in postmenopausal women. J Clin Endocrinol Metab 1999, 84(2):688-694.
29. Taylor A.E., McCourt B., Martin K.A., et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997, 82(7):2248-2256.
30. Pagan Y.L., Srouji S.S., Jimenez Y., et al. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab 2006, 91(4):1309-1316.
31. Srouji S.S., Pagan Y.L., D'Amato F., et al. Pharmacokinetic factors contribute to the inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome. J Clin Endocrinol Metab 2007, 92(4):1347-1352.
32. Hall J.E., Whitcomb R.W., Rivier J.E., et al. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists. J Clin Endocrinol Metab 1990, 70(2):328-335.
33. Marshall J.C., Dalkin A.C., Haisenleder D.J., et al. Gonadotropin-releasing hormone pulses: regulators of gonadotropin synthesis and ovulatory cycles. Recent Prog Horm Res 1991, 47:155-187.
34. Kaiser U.B. Molecular mechanisms of the regulation of gonadotropin gene expression by gonadotropin-releasing hormone. Mol Cells 1998, 8(6):647-656.
35. Gross K.M., Matsumoto A.M., Bremner W.J. Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man. J Clin Endocrinol Metab 1987, 64(4):675-680.
36. Spratt D.I., Finkelstein J.S., Butler J.P., et al. Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men. J Clin Endocrinol Metab 1987, 64(6):1179-1186.
37. Hall J.E., Taylor A.E., Hayes F.J., Crowley W.F. Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome. J Endocrinol Invest 1998, 21(9):602-611.
38. Bedecarrats G.Y., Kaiser U.B. Differential regulation of gonadotropin subunit gene promoter activity by pulsatile gonadotropin-releasing hormone (GnRH) in perifused L beta T2 cells: role of GnRH receptor concentration. Endocrinology 2003, 144(5):1802-1811.
39. Finkelstein J.S., Badger T.M., O'Dea L.S., et al. Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells. J Clin Invest 1988, 81(6):1725-1733.
40. O'Dea L.S., Finkelstein J.S., Schoenfeld D.A., et al. Interpulse interval of GnRH stimulation independently modulates LH secretion. Am J Physiol 1989, 256(4 Pt 1):E510-E515.
41. Bilezikjian L.M., Blount A.L., Donaldson C.J., Vale W.W. Pituitary actions of ligands of the TGF-beta family: activins and inhibins. Reproduction 2006, 132(2):207-215.
42. Norwitz E.R., Xu S., Jeong K.H., et al. Activin A augments GnRH-mediated transcriptional activation of the mouse GnRH receptor gene. Endocrinology 2002, 143(3):985-997.
43. Welt C., Sidis Y., Keutmann H., Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 2002, 227(9):724-752.
44. Kirk S.E., Dalkin A.C., Yasin M., et al. Gonadotropin-releasing hormone pulse frequency regulates expression of pituitary follistatin messenger ribonucleic acid: a mechanism for differential gonadotrope function. Endocrinology 1994, 135(3):876-880.
45. Morishima A., Grumbach M.M., Simpson E.R., et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995, 80(12):3689-3698.
46. Hall J.E., Gill S. Neuroendocrine aspects of aging in women. Endocrinol Metab Clin North Am 2001, 30(3):631-646.
47. Gharib S.D., Wierman M.E., Shupnik M.A., Chin W.W. Molecular biology of the pituitary gonadotropins. Endocr Rev 1990, 11(1):177-199.
48. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev 1999, 20(3):358-417.
49. Gill S., Sharpless J.L., Rado K., Hall J.E. Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women. J Clin Endocrinol Metab 2002, 87(5):2290-2296.
50. Rance N.E., Uswandi S.V. Gonadotropin-releasing hormone gene expression is increased in the medial basal hypothalamus of postmenopausal women. J Clin Endocrinol Metab 1996, 81(10):3540-3546.
51. Ottowitz W.E., Dougherty D.D., Fischman A.J., Hall J.E. FDG-PET reveals differential sites of estrogen negative and positive feedback on luteinizing hormone secretion in women. J Clin Endocrinol Metab 2008, 93(8):3208-3214.
52. Evans N.P., Dahl G.E., Glover B.H., Karsch F.J. Central regulation of pulsatile gonadotropin-releasing hormone (GnRH) secretion by estradiol during the period leading up to the preovulatory GnRH surge in the ewe. Endocrinology 1994, 134(4):1806-1811.
53. Chongthammakun S., Terasawa E. Negative feedback effects of estrogen on luteinizing hormone-releasing hormone release occur in pubertal, but not prepubertal, ovariectomized female rhesus monkeys. Endocrinology 1993, 132(2):735-743.
54. Rance N.E. Menopause and the human hypothalamus: evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback. Peptides 2009, 30(1):111-122.
55. Frawley L.S., Neill J.D. Biphasic effects of estrogen on gonadotropin-releasing hormone-induced luteinizing hormone release in monolayer cultures of rat and monkey pituitary cells. Endocrinology 1984, 114(2):659-663.
56. Nakai Y., Plant T.M., Hess D.L., et al. On the sites of the negative and positive feedback actions of estradiol in the control of gonadotropin secretion in the rhesus monkey. Endocrinology 1978, 102(4):1008-1014.
57. Marshall J.C., Case G.D., Valk T.W., et al. Selective inhibition of follicle-stimulating hormone secretion by estradiol: mechanism for modulation of gonadotropin responses to low dose pulses of gonadotropin-releasing hormone. J Clin Invest 1983, 71(2):248-257.
58. Welt C.K., Pagan Y.L., Smith P.C., et al. Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab 2003, 88(4):1766-1771.
59. Filicori M., Crowley W.F. The study of GnRH control of reproductive function. Ups J Med Sci 1984, 89(1):13-18.
60. Soules M.R., Steiner R.A., Clifton D.K., et al. Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. J Clin Endocrinol Metab 1984, 58(2):378-383.
61. Nippoldt T.B., Reame N.E., Kelch R.P., Marshall J.C. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle. J Clin Endocrinol Metab 1989, 69(1):67-76.
62. Scott C.J., Pereira A.M., Rawson J.A., et al. The distribution of progesterone receptor immunoreactivity and mRNA in the preoptic area and hypothalamus of the ewe: upregulation of progesterone receptor mRNA in the mediobasal hypothalamus by oestrogen. J Neuroendocrinol 2000, 12(6):565-575.
63. Bellantoni M.F., Harman S.M., Cullins V.E., et al. Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women. J Gerontol 1991, 46(6):M216-M222.
64. Cagnacci A., Melis G.B., Paoletti A.M., et al. Influence of oestradiol and progesterone on pulsatile LH secretion in postmenopausal women. Clin Endocrinol (Oxf) 1989, 31(5):541-550.
65. Gill S., Lavoie H.B., Bo-Abbas Y., Hall J.E. Negative feedback effects of gonadal steroids are preserved with aging in postmenopausal women. J Clin Endocrinol Metab 2002, 87(5):2297-2302.
66. Kepa J.K., Jacobsen B.M., Boen E.A., et al. Direct binding of progesterone receptor to nonconsensus DNA sequences represses rat GnRH. Mol Cell Endocrinol 1996, 117(1):27-39.
67. Lambert-Messerlian G.M., Hall J.E., Sluss P.M., et al. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 1994, 79(1):45-50.
68. Muttukrishna S., Fowler P.A., Groome N.P., et al. Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Hum Reprod 1994, 9(9):1634-1642.
69. Welt C.K., McNicholl D.J., Taylor A.E., Hall J.E. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999, 84(1):105-111.
70. Anawalt B.D., Bebb R.A., Matsumoto A.M., et al. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1986, 81(9):3341-3345.
71. Hayes F.J., Hall J.E., Boepple P.A., Crowley W.F. Clinical review 96: differential control of gonadotropin secretion in the human: endocrine role of inhibin. J Clin Endocrinol Metab 1998, 83(6):1835-1841.
72. Welt C.K., Martin K.A., Taylor A.E., et al. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. J Clin Endocrinol Metab 1997, 82(8):2645-2652.
73. Groome N.P., Illingworth P.J., O'Brien M., et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996, 81(4):1401-1405.
74. Groome N.P., Illingworth P.J., O'Brien M., et al. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf) 1994, 40(6):717-723.
75. Fujiwara T., Sidis Y., Welt C., et al. Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles. J Clin Endocrinol Metab 2001, 86(9):4206-4215.
76. Roberts V.J., Barth S., el Roeiy A., Yen S.S. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 1993, 77(5):1402-1410.
77. Majdic G., McNeilly A.S., Sharpe R.M., et al. Testicular expression of inhibin and activin subunits and follistatin in the rat and human fetus and neonate and during postnatal development in the rat. Endocrinology 1997, 138(5):2136-2147.
78. Shaha C., Morris P.L., Chen C.L., et al. Immunostainable inhibin subunits are in multiple types of testicular cells. Endocrinology 1989, 125(4):1941-1950.
79. Yamoto M., Minami S., Nakano R. Immunohistochemical localization of inhibin subunits in polycystic ovary. J Clin Endocrinol Metab 1993, 77(3):859-862.
80. Schneyer A.L., Rzucidlo D.A., Sluss P.M., Crowley W.F. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology 1994, 135(2):667-674.
81. Liu J.H., Yen S.S. Induction of midcycle gonadotropin surge by ovarian steroids in women: a critical evaluation. J Clin Endocrinol Metab 1983, 57(4):797-802.
82. Taylor A.E., Whitney H., Hall J.E., et al. Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women. J Clin Endocrinol Metab 1995, 80(5):1541-1547.
83. Turzillo A.M., Nolan T.E., Nett T.M. Regulation of gonadotropin-releasing hormone (GnRH) receptor gene expression in sheep: interaction of GnRH and estradiol. Endocrinology 1998, 139(12):4890-4894.
84. Clarke I.J. Multifarious effects of estrogen on the pituitary gonadotrope with special emphasis on studies in the ovine species. Arch Physiol Biochem 2002, 110(1-2):62-73.
85. Couzinet B., Brailly S., Bouchard P., Schaison G. Progesterone stimulates luteinizing hormone secretion by acting directly on the pituitary. J Clin Endocrinol Metab 1992, 74(2):374-378.
86. Xu M., Hill J.W., Levine J.E. Attenuation of luteinizing hormone surges in neuropeptide Y knockout mice. Neuroendocrinology 2000, 72(5):263-271.
87. Karsch F.J., Bowen J.M., Caraty A., et al. Gonadotropin-releasing hormone requirements for ovulation. Biol Reprod 1997, 56(2):303-309.
88. Krajnak K., Rosewell K.L., Wise P.M. Fos-induction in gonadotropin-releasing hormone neurons receiving vasoactive intestinal polypeptide innervation is reduced in middle-aged female rats. Biol Reprod 2001, 64(4):1160-1164.
89. Treloar A.E., Boynton R.E., Behn B.G., Brown B.W. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967, 12(1 Pt 2):77-126.
90. Levine J.E. New concepts of the neuroendocrine regulation of gonadotropin surges in rats. Biol Reprod 1997, 56(2):293-302.
91. Clarke I.J. Two decades of measuring GnRH secretion. Reprod Suppl 2002, 59:1-13.
92. Moenter S.M., Caraty A., Locatelli A., Karsch F.J. Pattern of gonadotropin-releasing hormone (GnRH) secretion leading up to ovulation in the ewe: existence of a preovulatory GnRH surge. Endocrinology 1991, 129(3):1175-1182.
93. Crowley W.F., Filicori M., Spratt D.I., Santoro N.F. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 1985, 41:473-531.
94. Adams J.M., Taylor A.E., Schoenfeld D.A., et al. The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency. J Clin Endocrinol Metab 1994, 79(3):858-864.
95. Hall J.E., Schoenfeld D.A., Martin K.A., Crowley W.F. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinol Metab 1992, 74(3):600-607.
96. Reame N., Sauder S.E., Kelch R.P., Marshall J.C. Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion. J Clin Endocrinol Metab 1984, 59(2):328-337.
97. Wang C.F., Lasley B.L., Lein A., Yen S.S. The functional changes of the pituitary gonadotrophs during the menstrual cycle. J Clin Endocrinol Metab 1976, 42(4):718-728.
98. Batista M.C., Cartledge T.P., Zellmer A.W., et al. The antiprogestin RU486 delays the midcycle gonadotropin surge and ovulation in gonadotropin-releasing hormone-induced cycles. Fertil Steril 1994, 62(1):28-34.
99. Ghosh B.R., Wu J.C., Strahl B.D., et al. Inhibin and estradiol alter gonadotropes differentially in ovine pituitary cultures: changing gonadotrope numbers and calcium responses to gonadotropin-releasing hormone. Endocrinology 1996, 137(11):5144-5154.
100. Fowler P.A., Sorsa T., Harris W.J., et al. Relationship between follicle size and gonadotrophin surge attenuating factor (GnSAF) bioactivity during spontaneous cycles in women. Hum Reprod 2001, 16(7):1353-1358.
101. Hall J.E., Taylor A.E., Martin K.A., et al. Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women. Proc Natl Acad Sci U S A 1994, 91(15):6894-6898.
102. Dubourdieu S., Charbonnel B., D'Acremont M.F., et al. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH. J Clin Endocrinol Metab 1994, 78(2):343-347.
103. Kolp L.A., Pavlou S.N., Urban R.J., et al. Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal women. J Clin Endocrinol Metab 1992, 75(4):993-997.
104. Martin K.A., Welt C.K., Taylor A.E., et al. Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model. Neuroendocrinology 1998, 67(6):363-369.
105. Filicori M., Butler J.P., Crowley W.F. Neuroendocrine regulation of the corpus luteum in the human: evidence for pulsatile progesterone secretion. J Clin Invest 1984, 73(6):1638-1647.
106. Le Nestour E., Marraoui J., Lahlou N., et al. Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition. J Clin Endocrinol Metab 1993, 77(2):439-442.
107. Lahlou N., Chabbert-Buffet N., Christin-Maitre S., et al. Main inhibitor of follicle stimulating hormone in the luteal-follicular transition: inhibin A, oestradiol, or inhibin B?. Hum Reprod 1999, 14(5):1190-1193.
108. McCartney C.R., Gingrich M.B., Hu Y., et al. Hypothalamic regulation of cyclic ovulation: evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone. J Clin Endocrinol Metab 2002, 87(5):2194-2200.
109. Preston F.S., Bateman S.C., Short R.V., Wilkinson R.T. The effects of flying and of time changes on menstrual cycle length and on performance in airline stewardesses. Biorhythms and Human Reproduction 1974,, 501-512. Wiley & Sons, New York. M. Ferin, F. Halberg, R.M. Richart, R.L. Vande Wiele (Eds.).
110. Miyauchi F., Nanjo K., Otsuka K. [Effects of night shift on plasma concentrations of melatonin, LH, FSH and prolactin, and menstrual irregularity]. Sangyo Igaku 1992, 34(6):545-550.
111. Schneyer A.L., Fujiwara T., Fox J., et al. Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations. J Clin Endocrinol Metab 2000, 85(9):3319-3330.
112. Welt C.K., Smith Z.A., Pauler D.K., Hall J.E. Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development. J Clin Endocrinol Metab 2001, 86(6):2531-2537.
113. Welt C.K., Schneyer A.L. Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab 2001, 86(1):330-336.
114. Vale W., Rivier C., Hsueh A., et al. Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 1988, 44:1-34.
115. Molskness T.A., Woodruff T.K., Hess D.L., et al. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys. J Clin Endocrinol Metab 1996, 81(11):4002-4006.
116. Stouffer R.L., Dahl K.D., Hess D.L., et al. Systemic and intraluteal infusion of inhibin A or activin A in rhesus monkeys during the luteal phase of the menstrual cycle. Biol Reprod 1994, 50(4):888-895.
117. Fraser H.M., Tsonis C.G. Manipulation of inhibin during the luteal-follicular phase transition of the primate menstrual cycle fails to affect FSH secretion. J Endocrinol 1994, 142(1):181-186.
118. Santoro N., Brown J.R., Adel T., Skurnick J.H. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996, 81(4):1495-1501.
119. Klein N.A., Battaglia D.E., Clifton D.K., et al. The gonadotropin secretion pattern in normal women of advanced reproductive age in relation to the monotropic FSH rise. J Soc Gynecol Investig 1996, 3(1):27-32.
120. Reame N.E., Wyman T.L., Phillips D.J., et al. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women. J Clin Endocrinol Metab 1998, 83(9):3302-3307.
121. Burger H.G., Cahir N., Robertson D.M., et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf) 1998, 48(6):809-813.
122. Santoro N., Adel T., Skurnick J.H. Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 1999, 71(4):658-662.
123. Richardson S.J. The biological basis of the menopause. Baillieres Clin Endocrinol Metab 1993, 7(1):1-16.
124. Burger H.G., Dudley E.C., Hopper J.L., et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999, 84(11):4025-4030.
125. Muttukrishna S., Fowler P.A., George L., et al. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab 1996, 81(9):3328-3334.
126. Demura R., Suzuki T., Tajima S., et al. Human plasma free activin and inhibin levels during the menstrual cycle. J Clin Endocrinol Metab 1993, 76(4):1080-1082.
127. Vihko K.K., Blauer M., Kujansuu E., Activin B., et al. detection by an immunoenzymometric assay in human serum during ovarian stimulation and late pregnancy. Hum Reprod 1998, 13(4):841-846.
128. Conn P.M., Crowley W.F. Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994, 45:391-405.
129. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev 1999, 20(3):358-417.
130. Crowley W.F., Pitteloud N., Seminara S. New genes controlling human reproduction and how you find them. Trans Am Clin Climatol Assoc 2008, 119:29-38.
131. Hall J.E. Neuroendocrine physiology of the early and late menopause. Endocrinol Metab Clin North Am 2004, 33(4):637-659.
132. Herbison A.E. Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. Endocr Rev 1998, 19(3):302-330.
133. Kaiser U.B. Molecular mechanisms of the regulation of gonadotropin gene expression by gonadotropin-releasing hormone. Mol Cells 1998, 8(6):647-656.
134. Karsch F.J., Bowen J.M., Caraty A., et al. Gonadotropin-releasing hormone requirements for ovulation. Biol Reprod 1997, 56(2):303-309.
135. Neill J.D. GnRH and GnRH receptor genes in the human genome. Endocrinology 2002, 143(3):737-743.
136. Seminara S.B. Kisspeptin in reproduction. Semin Reprod Med 2007, 25(5):337-343.
137. Welt C., Sidis Y., Keutmann H., Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 2002, 227(9):724-752.